Maria Rasmussen Selected Research

CTLA-4 Antigen

12/2022

Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Rasmussen Research Topics

Disease

4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023 - 01/2021
4	Neoplasms (Cancer) 01/2023 - 01/2021
2	Microsatellite Instability 01/2023 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2020
2	Turcot syndrome 01/2023 - 01/2021
2	Crohn Disease (Crohn's Disease) 08/2018 - 01/2017
2	Ascites 01/2008 - 01/2007
1	Hypokalemia 01/2024
1	Alkalosis 01/2024
1	Liddle Syndrome 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Pain (Aches) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Hypophosphatasia 01/2023
1	Nephrolithiasis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Infantile Hypercalcemia 01/2022
1	Nephrocalcinosis 01/2022
1	Cysts 11/2021
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 08/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Ulcerative Colitis 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Hereditary renal agenesis 01/2017
1	Body Weight (Weight, Body) 11/2009
1	Hyperphagia (Overeating) 11/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
2	avelumabIBA 12/2022 - 01/2021
2	atezolizumabIBA 12/2022 - 01/2021
2	pembrolizumabIBA 12/2022 - 01/2021
2	IpilimumabIBA 12/2022 - 01/2021
2	NivolumabIBA 12/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2021
2	durvalumabIBA 12/2022 - 01/2021
2	LigandsIBA 12/2022 - 11/2021
2	Infliximab (Remicade)FDA Link 08/2018 - 01/2017
1	AldosteroneIBA 01/2024
1	ReninIBA 01/2024
1	PromegaIBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2023
1	Vitamin B 6IBA 01/2023
1	CTLA-4 AntigenIBA 12/2022
1	Vitamin D3 24-HydroxylaseIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Aprotinin (Trasylol)FDA Link 11/2021
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 11/2021
1	Aquaporin 2IBA 11/2021
1	5' Untranslated Regions (5' UTR)IBA 08/2021
1	insulin receptor-related receptor (IRR)IBA 04/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 11/2009
1	Peptides (Polypeptides)IBA 11/2009
1	Ghrelin ReceptorsIBA 11/2009
1	radixinIBA 01/2008
1	moesinIBA 01/2008
1	Green Fluorescent ProteinsIBA 01/2008
1	ezrinIBA 01/2008
1	ethylisopropylamiloride (EIPA)IBA 01/2007
1	cariporideIBA 01/2007
1	Mitogen-Activated Protein KinasesIBA 01/2007

Therapy/Procedure

3	Therapeutics 12/2022 - 08/2018
2	Immunotherapy 01/2023 - 01/2021